- Home
- NPWR.WS vs CRVO Comparison
NPWR.WS vs CRVO Comparison
Compare NPWR.WS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
NPWR.WS
NET Power Inc. Redeemable warrants each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
N/A
Current Price
$1.37
Company Overview
Basic Information| Metric | NPWR.WS | CRVO |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6M | 21.5M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | NPWR.WS | CRVO |
|---|---|---|
| Price | $0.11 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.80 |
| AVG Volume (30 Days) | N/A | ★ 324.3K |
| Earning Date | N/A | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,006,510.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | N/A | $1.27 |
| 52 Week High | N/A | $10.00 |
Technical Indicators
Market Signals| Indicator | NPWR.WS | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 21.87 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $3.86 |
| Average True Range (ATR) | 0.00 | 0.18 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 0.00 | 6.48 |
Price Performance
Historical Comparison NPWR.WS
CRVO
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.